CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a recent >10% stock rally. See more.

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’

Shares of CVS Health (NYSE: CVS) were soaring Wednesday after the diversified healthcare giant's fourth-quarter results topped estimates and management offered better-than-expected guidance for 2025.

CVS Health investors were breathing a big sigh of relief Wednesday after the healthcare services behemoth reported better-than-expected quarterly earnings. Shares were up sharply on hopes that the company’s atrociously bad 2024 was now firmly in the rearview,

Leerink Partnrs upgraded shares of CVS Health (NYSE:CVS – Free Report) from a hold rating to a strong-buy rating in a research note published on Wednesday,Zacks.com reports. Leerink Partnrs also issued estimates for CVS Health’s FY2027 earnings at $8.

Good morning, and thank you all for attending the CVS Health Q4 2024 earnings conference call. My name is Brika, and I will be your moderator for today's call. [Operator instructions] I would now like to pass the conference over to your host,

Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market opens on